Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Hepatology Année : 2013

Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.

Résumé

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and hepatocellular carcinoma worldwide. Furthermore, HCV-induced liver disease is a major indication of liver transplantation. In the past years, direct-acting antivirals (DAAs) targeting HCV enzymes have been developed. DAAs increase the virologic response to anti-HCV therapy but may lead to selection of drug-resistant variants and treatment failure. To date, strategies to prevent HCV infection are still lacking and antiviral therapy in immunocompromised patients, patients with advanced liver disease and HIV/HCV-co-infection remains limited. Alternative or complementary approaches addressing the limitations of current antiviral therapies are to boost the host's innate immunity or interfere with host factors required for pathogenesis. Host-targeting agents (HTAs) provide an interesting perspective for novel antiviral strategies against viral hepatitis since they have (i) a high genetic barrier to resistance, (ii) a pan-genotypic antiviral activity, and (iii) complementary mechanisms of action to DAAs and might therefore act in a synergistic manner with current standard of care or DAAs in clinical development. This review highlights HTAs against HCV infection that have potential as novel antivirals and are in preclinical or clinical development.
Fichier principal
Vignette du fichier
JHEPAT-D-12-01308_R1_Figures.pdf (230.94 Ko) Télécharger le fichier
JHEPAT-D-12-01308_R1_Table_1.pdf (12.63 Ko) Télécharger le fichier
JHEPAT-D-12-01308_R1_manuscript.pdf (210.07 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-00741430 , version 1 (12-10-2012)

Identifiants

Citer

Mirjam B. Zeisel, Joachim Lupberger, Isabel Fofana, Thomas F. Baumert. Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.. Journal of Hepatology, 2013, 58 (2), pp.375-84. ⟨10.1016/j.jhep.2012.09.022⟩. ⟨inserm-00741430⟩

Collections

INSERM SITE-ALSACE
143 Consultations
514 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More